Preprint
Review

This version is not peer-reviewed.

Body Composition Monitoring in Older Adults on GLP-1 Receptor Agonists A Narrative Review of Assessment Methods

Submitted:

13 November 2026

Posted:

17 November 2026

You are already at the latest version

Abstract
Objective: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) produce marked weight loss. A meaningful proportion of that loss is lean tissue including muscle, and the effects of GLP-1RAs on bone remain uncertain. Older adults are vulnerable to morbidity and mortality caused by muscle and bone density loss, and body weight alone cannot detect these changes. This narrative literature review evaluated body composition assessment methods for monitoring older adults receiving GLP-1RAs. Methods: PubMed was searched from inception to August 2026. Studies were included if they evaluated the accuracy, repeatability, or ability to detect change of a body composition assessment method in adults. Methods were grouped as reference-standard, clinically accessible, or emerging scalable technologies. Results: Thirteen studies were included (nine primary studies and four reviews or methodological guides). Two primary studies enrolled older adults, and one measured body composition during GLP-1RA treatment. Dual-energy X-ray absorptiometry (DXA) was the most practical reference method because it assesses lean mass, fat mass, and bone mineral density in one scan, but its precision declined with obesity and estimates differed between systems. Bioelectrical impedance analysis was highly repeatable, but accuracy varied widely between devices. Smartphone applications and three-dimensional optical imaging were the most scalable, but their apparent accuracy depended on the reference system and participant posture, and neither has been validated in older adults or for tracking change. None of the accessible or emerging methods measured bone. Conclusions: No current method is both valid and scalable for monitoring body composition in older adults receiving GLP-1RAs. Longitudinal validation in this population, with agreement reported on change scores, is needed before monitoring-guided care can be tested.
Keywords: 
;  ;  ;  ;  ;  ;  ;  ;  ;  
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.